Avago Technologies Inactive 10-Q13 Mar 142014 Q1 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information Document	3 Months Ended
Document and Entity Information Document	Feb. 02, 2014	Feb. 28, 2014
Entity Information [Line Items]	'	'
Entity Registrant Name	'Avago Technologies LTD	'
Entity Central Index Key	'0001441634	'
Current Fiscal Year End Date	'--11-02	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	2-Feb-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	249,830,347

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets - Unaudited (USD $)	Feb. 02, 2014	Nov. 03, 2013
In Millions, unless otherwise specified	Feb. 02, 2014	Nov. 03, 2013
Current assets:	'	'
Cash and cash equivalents	$1,112	$985	[1]
Trade accounts receivable, net	323	418	[1]
Inventory	286	285	[1]
Other current assets	138	130	[1]
Total current assets	1,859	1,818	[1]
Property, plant and equipment, net	684	661	[1]
Goodwill	392	391	[1]
Intangible Assets, Net	467	492	[1]
Other long-term assets	70	53	[1]
Total assets	3,472	3,415	[1]
Current liabilities:	'	'
Accounts payable	257	278	[1]
Employee compensation and benefits	59	98	[1]
Capital lease obligations - current	1	1	[1]
Other current liabilities	47	46	[1]
Total current liabilities	364	423	[1]
Long-term liabilities:	'	'
Capital lease obligations - non-current	1	1	[1]
Other long-term liabilities	115	105	[1]
Total liabilities	480	529	[1]
Commitments and contingencies (Note 12)	'	'	[1]
Shareholders' equity:	'	'
Ordinary shares, no par value; 249,672,096 shares and 249,100,178 shares issued and outstanding on February 2, 2014 and November 3, 2013, respectively	1,622	1,587	[1]
Retained earnings	1,377	1,305	[1]
Accumulated other comprehensive loss	-7	-6	[1]
Total shareholders' equity	2,992	2,886	[1]
Total liabilities and shareholders' equity	$3,472	$3,415	[1]

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets - Unaudited Consolidated Balance Sheet (Parenthetical)	Feb. 02, 2014	Nov. 03, 2013
Common Stock, Shares, Issued	249,672,096	249,100,178
Common Stock, Shares, Outstanding	249,672,096	249,100,178

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations - Unaudited (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013
Net revenue	$709	$576
Cost of products sold:	'	'
Cost of products sold	347	286
Amortization of intangible assets	18	14
Restructuring charges	5	0
Total cost of products sold	370	300
Gross margin	339	276
Research and development	107	93
Selling, general and administrative	74	53
Amortization of intangible assets	7	5
Restructuring charges	12	1
Total operating expenses	200	152
Income from operations	139	124
Other income, net	0	2
Income before income taxes	139	126
Provision for income taxes	5	1
Net income	$134	$125
Net income per share:	'	'
Basic	$0.54	$0.51
Diluted	$0.53	$0.50
Weighted average shares :	'	'
Basic	249	246
Diluted	255	251
Cash dividends declared and paid per share	$0.25	$0.17

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income - Unaudited (USD $)	3 Months Ended
In Millions, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013
Net income	$134	$125
Unrealized gains of post-retirement plan and defined benefit pension plans, net of tax	0	2
Other Comprehensive Income (Loss), Finalization of Pension and Other Postretirement Benefit Plan Valuation, Net of Tax	-2	0
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit) Arising During Period, Net of Tax	1	0
Other comprehensive income (loss)	-1	2
Total comprehensive income	$133	$127

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows - Unaudited (USD $)	3 Months Ended
In Millions, unless otherwise specified	Feb. 02, 2014		Feb. 03, 2013
Cash flows from operating activities:	'		'
Net income	$134		$125
Adjustments to reconcile net income to net cash provided by operating activities:	'		'
Depreciation and amortization	57		41
Share-based compensation	24		17
Tax benefit from share-based compensation	4		0
Excess tax benefits from share-based compensation	-3		0
Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements and Curtailments	-3		0
Unrealized (gain)/loss on trading securities	0		-2
Changes in assets and liabilities, net of acquisitions:	'		'
Trade accounts receivable, net	95		75
Inventory	-1		-14
Accounts payable	-24		-34
Employee compensation and benefits	-39		-13
Deferred tax assets and liabilities	-3		1
Other current assets and current liabilities	-13		-12
Other long-term assets and long-term liabilities	1		1
Net cash provided by operating activities	229		185
Cash flows from investing activities:	'		'
Purchase of property, plant and equipment	-52		-67
Acquisitions and investments, net of cash acquired	0		-9
Net cash used in investing activities	-52		-76
Cash flows from financing activities:	'		'
Proceeds from government grants	2		3
Issuance of ordinary shares	19		10
Repurchases of ordinary shares	-12		-13
Excess tax benefits from share-based compensation	3		0
Dividend payments to shareholders	-62		-42
Net cash used in financing activities	-50		-42
Net (decrease) increase in cash and cash equivalents	127		67
Cash and cash equivalents at the beginning of period	985	[1]	1,084
Cash and cash equivalents at end of period	$1,112		$1,151

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Overview_and_Basis_of_Presenta

Overview and Basis of Presentation	3 Months Ended
	Feb. 02, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Overview and Basis of Presentation	'
	Overview, Basis of Presentation and Significant Accounting Policies
	Overview
	Avago Technologies Limited, or the “Company”, was organized under the laws of the Republic of Singapore in August 2005. We are a designer, developer and global supplier of analog semiconductor devices with a focus on III-V based products. We offer products in three primary target markets: wireless communications, wired infrastructure and industrial & other. Applications for our products in these target markets include cellular phones, consumer appliances, data networking and telecommunications equipment, enterprise storage and servers, factory automation and displays. References herein to "the Company", "we", "our", "us" and "Avago" are to Avago Technologies Limited and its consolidated subsidiaries, unless otherwise specified or the context otherwise requires.
	Basis of Presentation
	Fiscal Periods. We operate on a 52- or 53-week fiscal year ending on the Sunday closest to October 31. Our fiscal year ending November 2, 2014, or fiscal year 2014, is a 52-week fiscal year. The first quarter of our fiscal year 2014 ended on February 2, 2014, the second quarter will end on May 4, 2014, the third quarter will end on August 3, 2014 and the fourth quarter will end on November 2, 2014. Our fiscal year ended November 3, 2013, or fiscal year 2013, was a 53-week fiscal year, with our first fiscal quarter containing 14 weeks.
	Information. The unaudited condensed consolidated financial statements include the accounts of Avago Technologies Limited and all of its wholly-owned subsidiaries, and are prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP. Intercompany transactions and balances have been eliminated in consolidation.
	During fiscal year 2013, we completed our acquisition of CyOptics, Inc., or CyOptics. The unaudited condensed consolidated financial statements include the results of operations of CyOptics commencing as of the closing date of the acquisition. (See Note 3. "Acquisitions")
	Interim information presented in the unaudited condensed consolidated financial statements has been prepared by management and, in the opinion of management, includes all adjustments of a normal recurring nature that are necessary for the fair statement of the financial position, results of operations, comprehensive income and cash flows for the periods shown, and is in accordance with GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the fiscal year ended November 3, 2013, or fiscal year 2013, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on December 20, 2013.
	The operating results for the fiscal quarter ended February 2, 2014 are not necessarily indicative of the results that may be expected for fiscal year 2014, or for any other future period. The balance sheet data as of November 3, 2013 presented are derived from the audited consolidated financial statements as of that date.
	Significant Accounting Policies
	Use of estimates. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods.
	Concentrations of credit risk and significant customers. Our cash, cash equivalents and accounts receivable are potentially subject to concentration of credit risk. Cash and cash equivalents may be redeemable upon demand and are maintained with several financial institutions that management believes are of high credit quality and therefore bear minimal credit risk. We seek to mitigate our credit risks by spreading such risks across multiple counterparties and monitoring the risk profile of these counterparties. Our accounts receivable are derived from revenue earned from customers located in the U.S. and internationally. We mitigate collection risks from our customers by performing regular credit evaluations of our customers' financial conditions, and require collateral, such as letters of credit and bank guarantees, in certain circumstances.
	We sell our products through our direct sales force, distributors and manufacturers' representatives. One direct customer accounted for 26% of our net accounts receivable balance at both February 2, 2014 and November 3, 2013. For the fiscal quarter ended February 2, 2014, one direct customer represented 25% of our net revenue. For the fiscal quarter ended February 3, 2013, one direct customer represented 21% of our net revenue.
	Warranty. We accrue for the estimated costs of product warranties at the time revenue is recognized. Product warranty costs are estimated based upon our historical experience and specific identification of product requirements, which may fluctuate based on product mix. Additionally, we accrue for warranty costs associated with occasional or unanticipated product quality issues if a loss is probable and can be reasonably estimated. Warranty costs were not material for either of the fiscal quarters ended February 2, 2014 or February 3, 2013.
	Net income per share. Basic net income per share is computed using the weighted-average number of ordinary shares outstanding during the period. Diluted net income per share is computed using the weighted-average number of ordinary shares and potentially dilutive share equivalents outstanding during the period. Diluted shares outstanding includes the dilutive effect of in-the-money options (including market-based share options), restricted share units, or RSUs, and employee share purchase rights under the Avago Technologies Limited Employee Share Purchase Plan, or ESPP. The dilutive effect of such equity awards is calculated based on the average share price for each fiscal period, using the treasury stock method. Under the treasury stock method, the amount the employee must pay for exercising share options and to purchase shares under the ESPP, the amount of compensation cost for future service that the Company has not yet recognized, and the amount of tax benefits that would be recorded in an ordinary shares account when equity awards become deductible for income tax purposes are collectively assumed to be used to repurchase ordinary shares.
	Diluted net income per share for the fiscal quarter ended February 2, 2014 and the fiscal quarter ended February 3, 2013 excluded the potentially dilutive effect of weighted-average outstanding equity awards (options, RSUs and ESPP rights) to acquire 1 million and 2 million ordinary shares respectively, as their effect was antidilutive.
	The following is a reconciliation of the basic and diluted net income per share computations for the periods presented (in millions, except per share data):


		Fiscal Quarter Ended
		February 2,		February 3,
		2014		2013
	Net income (Numerator):
	Net income	$	134	$	125

	Shares (Denominator):
	Basic weighted-average ordinary shares outstanding	249		246

	Add incremental shares for:
	Dilutive effect of share options, RSUs and ESPP rights	6		5

	Shares used in diluted computation	255		251

	Net income per share:
	Basic	$	0.54	$	0.51

	Diluted	$	0.53	$	0.5

	Supplemental cash flow disclosures. At February 2, 2014 and November 3, 2013, we had $34 million and $31 million, respectively, of unpaid purchases of property, plant, and equipment included in accounts payable and other current liabilities. Amounts reported as unpaid purchases will be recorded as cash outflows from investing activities for purchases of property, plant, and equipment in the unaudited condensed consolidated statement of cash flows for the period in which they are paid.
	Recently Adopted Accounting Guidance
	In the first quarter of fiscal year 2014, we adopted guidance issued by the Financial Accounting Standards Board, or FASB, relating to reporting on reclassifications out of accumulated other comprehensive income (loss). This guidance seeks to improve the reporting of such reclassifications by requiring an entity to report the effect of significant reclassifications out of accumulated other comprehensive income (loss) on the respective line items in net income if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under GAAP that provide additional detail about those amounts. The amendments in this guidance supersede the presentation requirements for reclassifications out of accumulated other comprehensive income (loss) in previously issued guidance. The adoption of this guidance affected the presentation of comprehensive income, but did not have any impact our financial condition or results of operations.
	Recent Accounting Guidance Not Yet Adopted
	In July 2013, the FASB issued an amendment to the accounting guidance related to the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. The guidance requires an unrecognized tax benefit to be presented as a decrease in a deferred tax asset where a net operating loss, a similar tax loss or a tax credit carryforward exists and certain criteria are met. This guidance will be effective for the first quarter of our fiscal year 2015. The adoption of this guidance will affect the presentation of our unrecognized tax benefits but will not impact the Company's financial condition or results of operations.

Inventory

Inventory	3 Months Ended
	Feb. 02, 2014
Inventory Disclosure [Abstract]	'
Inventory	'
	Inventory
	Inventory consists of the following (in millions):


		February 2,		November 3,
		2014		2013
	Finished goods	$	56	$	53

	Work-in-process	146		154

	Raw materials	84		78

	Total inventory	$	286	$	285

Acquisitions

Acquisitions	3 Months Ended
	Feb. 02, 2014
Business Combinations [Abstract]	'
Acquisitions and Investment	'
	Acquisitions

	Pending Merger with LSI Corporation
	On December 15, 2013, we entered into a merger agreement with LSI Corporation, or LSI, a U.S. publicly traded company that designs semiconductors and software that accelerate storage and networking in data centers, mobile networks and client computing. Pursuant to the merger agreement, we have agreed to acquire all of the issued and outstanding shares of common stock of LSI for an aggregate acquisition consideration of approximately $6.6 billion in cash, or $11.15 in cash per share of LSI common stock. Under the merger agreement, we will also assume all unvested LSI stock options and restricted stock units held by continuing employees and service providers. All vested LSI stock options and restricted stock units, after giving affect to any acceleration, will be settled in cash at the effective time of the merger and any remaining unvested LSI stock options and restricted stock units will be cancelled for no consideration.
	The transaction has been approved by the Avago and LSI boards of directors and is subject to the satisfaction of customary closing conditions, including the receipt of regulatory approvals in various jurisdictions, as well as approval of LSI's stockholders. The merger agreement contains certain termination rights for Avago and LSI, and provides that, upon termination of the merger agreement under certain specified circumstances, LSI will be obligated to pay Avago a termination fee of $200 million and Avago will be obligated to pay LSI a termination fee of $400 million. There are no financing contingencies related to the acquisition. The transaction is presently expected to close in the first half of calendar year 2014.
	We expect to finance the transaction with $1.0 billion of cash from the combined company balance sheets, $4.6 billion of fully committed term loans from a group of banks and $1.0 billion in proceeds from the private placement of 2% Convertible Senior Notes (referred to as the Convertible Notes), or preferred stock with equivalent economic terms, to an investment fund affiliated with Silver Lake Partners. The completion of the private placement of the Convertible Notes is contingent on satisfaction or waiver of customary conditions, as well as a requirement that the merger with LSI be consummated and that Avago shall have simultaneously or substantially simultaneously received the proceeds of the committed term loan debt financing referenced above. The initial conversion rate for the Convertible Notes is 20.8160 shares of Avago’s ordinary shares per $1,000 principal amount of Convertible Notes, which is equivalent to an initial conversion price of approximately $48.04 per Avago ordinary shares. In addition, we expect to enter into a new $500 million secured revolving credit facility.
	CyOptics
	On June 28, 2013, we completed our acquisition of all of the outstanding shares of capital stock of CyOptics, Inc., a U.S.-based company that manufactures and sells Indium Phosphide, or InP, optical chip and component technologies for the data communications and telecommunications markets. CyOptics has front-end manufacturing operations in the U.S. and back-end manufacturing operations in Mexico. As a result of the CyOptics acquisition, we acquired approximately 1,100 additional employees, with 745 of these employees located in Mexico.
	The aggregate consideration for the acquisition was approximately $377 million (including a $1 million working capital adjustment payment made in the fiscal quarter ended November 3, 2013), of which $373 million was paid in cash, net of $3 million in cash acquired. We also agreed to pay additional deferred consideration to the previous shareholders of CyOptics in the amount of $4 million one year subsequent to the acquisition date, which was recorded in other current liabilities.
	An additional approximately $27 million is payable to key employees of CyOptics as part of a retention bonus plan. This amount was paid into escrow and will be paid to those employees over a three-year period subsequent to the acquisition date and is being recognized as compensation expense in operating results over the same period. For eligible CyOptics employees whose employment is involuntarily terminated by the Company, their retention bonus payments are accelerated and due in full upon such termination in accordance with the provisions of the plan. During the first quarter of fiscal year 2014, we recorded a compensation expense of $9 million due to the departures of certain plan participants.
	We have preliminarily estimated the fair value of the acquired assets and liabilities for CyOptics. We allocated the purchase price to tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair values. The excess of the purchase price over the aggregate fair values was recorded as goodwill. The fair value assigned to identifiable intangible assets acquired was based on estimates and assumptions made by management at the time of acquisition. As additional information becomes available, such as finalization of negotiations of working capital adjustments and tax related matters, we have revised and may continue to revise our preliminary purchase price allocation.
	During the fourth quarter of fiscal year 2013, adjustments were made to account for a $10 million increase to fixed assets, based on the result of the physical inventory of fixed assets, a $4 million increase in deferred tax liabilities relating to the fixed asset adjustment, a $3 million increase in deferred tax liabilities related to measurement period tax positions and a $1 million increase in consideration paid due to payments related to working capital adjustments. These adjustments resulted in a $2 million decrease in the fair value assigned to goodwill related to post-acquisition fixed assets counts, working capital settlement and deferred tax adjustments.
	Our preliminary allocation of the total purchase price for CyOptics and the purchased intangible assets as of February 2, 2014 is as follows (in millions):


		Estimated Fair Value
	Trade accounts receivable	$	51

	Inventory	35

	Other current assets	2

	Property, plant and equipment	44

	Goodwill	190

	Intangible assets	141

	Total assets acquired	463

	Accounts payable	(25		)
	Employee compensation and benefits	(5		)
	Other current liabilities	(2		)
	Long-term deferred tax liabilities (included in Other long-term liabilities)	(54		)
	Total liabilities assumed	(86		)
	Purchase price allocation	$	377

	There were no significant contingencies assumed as part of the acquisition. As of February 2, 2014, we have recorded $12 million in indemnification receivables in other long-term assets for tax positions related to CyOptics' value-added tax and income tax payables existing prior to the acquisition.


		Estimated Fair Value			Estimated Useful
		(in millions)			Lives (in years)
	Purchased intangible assets
	Purchased technology - base product	$	98		8

	Purchased technology - packaging	3			5

	Customer relationships	32			7

	Other - customer backlog	4			1

	Total identified intangible finite lived assets	137

	In process research and development indefinite lived assets	4

	Total identified intangible assets	$	141

	Purchased Intangible Assets. Developed technology represents base product technology and packaging technology. We valued the base product technology that generates cash flows from sales of the existing products using the income approach, specifically the multi-period excess earnings method which calculates the value based on the risk-adjusted present value of the cash flows specific to the products, allowing for a reasonable return. The useful life of 8 years was determined based on the technology cycle related to the base product technology as well as the life of current legacy products.
	Packaging technology is valued utilizing the relief-from-royalty method, a form of the income approach. The relief-from-royalty method estimates the cost savings that accrue to the owner of an intangible asset that would otherwise be payable as royalties or license fees on revenues earned through the use of the asset. The royalty rate is based on an analysis of empirical, market-derived royalty rate for guideline intangible assets.
	Customer relationships represent the fair value of future projected revenue that will be derived from sales of products to existing customers of CyOptics. Customer relationships were valued using the with-and-without-method, a form of the income approach. In this method, fair value is measured by the lost profits associated with the period of time necessary to reacquire the customers. The method involves a comparison of the cash flows assuming the customer relationships were in place versus as if the customer relationships were to be created "from scratch." There are additional considerations related to the build-in time for certain product lines and the qualification periods included in the valuation model. This method also assumes that all other assets, know-how and technology were easily available in both scenarios.
	The fair value of in-process research and development, or IPR&D, from the CyOptics acquisition was determined using the multi-period excess earnings method, a form of the income approach. Under the income approach, the expected future cash flows from each project under development are estimated and discounted to their net present values at an appropriate risk-adjusted rate of return.
	We believe the amount recorded as developed technology, IPR&D and customer relationships, represent the fair value of and approximate the amount a market participant would pay for these projects as of the acquisition date.
	The purchased intangible assets are being amortized over their estimated useful lives of 1 year to 8 years. (See Note 4. Goodwill and Intangible Assets)
Unaudited Pro Forma Information. The following table presents certain unaudited pro forma financial information for each of the fiscal years ended November 3, 2013 and October 28, 2012 as if CyOptics had been acquired as of the beginning of the fiscal year prior to the acquisition date. The unaudited estimated pro forma information combines the historical results of CyOptics with our consolidated historical results and includes certain fair value adjustments reflecting the estimated impact of amortization of purchased intangible assets and depreciation of acquired property, plant and equipment for the respective periods. The pro forma data are for informational purposes only and are not necessarily indicative of the consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of our fiscal year 2012 or of the results of future operations of the combined business. Consequently, actual results will differ from the unaudited pro forma information presented below (in millions, except for per share amounts):


	Fiscal Year Ended
	3-Nov-13				28-Oct-12
Pro forma net revenue	$	2,663			$	2,578

Pro forma net income	$	547			$	551

Pro forma net income per share-basic	$	2.21			$	2.25

Pro forma net income per share-diluted	$	2.17			$	2.2

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	3 Months Ended
	Feb. 02, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets	'
	Goodwill and Intangible Assets
	Goodwill
	There were no material change in the goodwill balance for the period ended February 2, 2014.
	Intangible Assets
	Purchased intangibles consist of the following (in millions):


		Gross Carrying		Accumulated			Net Book Value
		Amount		Amortization
	As of February 2, 2014:
	Purchased technology	$	843	$	(480	)	$	363

	Customer and distributor relationships	289		(192		)	97

	Other	8		(5		)	3

	Intangible assets subject to amortization	1,140		(677		)	463

	In-process research and development	4		—			4

	Total	$	1,144	$	(677	)	$	467


	As of November 3, 2013:
	Purchased technology	$	843	$	(462	)	$	381

	Customer and distributor relationships	289		(186		)	103

	Other	8		(4		)	4

	Intangible assets subject to amortization	1,140		(652		)	488

	In-process research and development	4		—			4

	Total	$	1,144	$	(652	)	$	492

	The following table presents the amortization expense of purchased intangible assets (in millions):


		Fiscal Quarter Ended
		February 2,		February 3,
		2014		2013
	Cost of products sold	$	18	$	14

	Operating expenses	7		5

	Total amortization expense	$	25	$	19

	Based on the amount of intangible assets subject to amortization at February 2, 2014, the expected amortization expense for each of the next five fiscal years and thereafter is as follows (in millions):


	Fiscal Year	Amount
	2014 (remainder)	$	74

	2015	95

	2016	78

	2017	68

	2018	33

	2019	29

Thereafter	86

	$	463

The weighted-average amortization periods remaining by intangible asset category at February 2, 2014 were as follows (in years):


Amortizable intangible assets:
Purchased technology	7
Customer and distributor relationships	6
Other	9

Retirement_Plans_and_PostRetir

Retirement Plans and Post-Retirement Benefits	3 Months Ended
Retirement Plans and Post-Retirement Benefits	Feb. 02, 2014
Compensation and Retirement Disclosure [Abstract]	'
Retirement Plans and Post-Retirement Benefits	'
	Retirement Plans and Post-Retirement Benefits
	An amendment was made to our U.S. post-retirement medical benefit plan with an effective date of January 1, 2014. This plan was transferred to us from Agilent Technologies, Inc., or Agilent, as part of the Semiconductor Products Group, or SPG, acquisition on December 1, 2005. The amendment affected active, eligible employees and had no impact on existing retirees. As a result of the amendment, employees who were previously eligible for the medical benefit spending account of $40,000 upon retirement received a cash settlement based on age and years of service and have ceased to be eligible for post-retirement medical benefits under the program. During the first quarter of fiscal year 2014, we paid an aggregate of $6 million in cash into these employees' 401(k) accounts. Employees who were previously eligible for the medical benefit spending account of $55,000 upon retirement, have had the period during which they, as retirees, may use the spending account to pay premiums paid for medical coverage extended from age 65 to 75. Employees who were previously eligible for the traditional retiree medical plan upon retirement have ceased to be eligible to participate in such a plan and will, instead, only be eligible for the extended $55,000 retiree medical account program described above. As a result of the above plan amendment, a curtailment gain of $1 million and a settlement gain of $2 million were recorded in the unaudited condensed consolidated financial statements for the fiscal quarter ended February 2, 2014. As of February 2, 2014, the U.S. post-retirement medical benefit plan's remaining liability balance was $14 million, which is primarily included in other long-term liabilities in our unaudited condensed consolidated balance sheet.

Borrowings

Borrowings	3 Months Ended
Borrowings	Feb. 02, 2014
Debt Disclosure [Abstract]	'
Borrowings	'
	Borrowings
	We had no borrowings as of February 2, 2014 and November 3, 2013 with respect to the 2013 unsecured revolving credit facility. We were in compliance with the financial covenants under our credit agreement as of February 2, 2014.
	Debt issuance cost
	Unamortized debt issuance costs associated with our 2013 unsecured revolving credit facility were $2 million at February 2, 2014 and are included in other current assets and other long-term assets on the condensed consolidated balance sheets. Amortization of debt issuance costs is classified as interest expense in the unaudited condensed consolidated statements of operations.

Fair_Value

Fair Value	3 Months Ended
	Feb. 02, 2014
Fair Value Disclosures [Abstract]	'
Fair Value	'
	Fair Value
	Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three level hierarchy is applied to prioritize the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
	The three levels of the fair value hierarchy under the guidance for fair value measurements are described below:
	Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Our Level 1 assets include bank acceptances, trading securities investments and investment funds (i.e., deferred compensation plan assets). We measure trading securities investments and investment funds at quoted market prices as they are traded in an active market with sufficient volume and frequency of transactions. As of February 2, 2014, the fair market value of a minority interest equity investment was $14 million and classified as trading securities in other current assets on the unaudited condensed consolidated balance sheets.
	Level 2—Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability.
	Level 3—Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments, goodwill, amortizable intangible assets, and property, plant and equipment, which are measured at fair value using a discounted cash flow approach when they are impaired. Quantitative information for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee's ability to continue as a going concern.
	We did not have any Level 3 asset or liability activities during the fiscal quarter ended February 2, 2014.
	Assets and Liabilities Measured at Fair Value on a Recurring Basis
	The table below sets forth by level our financial assets and liabilities that were accounted for at fair value as of February 2, 2014. The table does not include cash on hand and also does not include assets that are measured at historical cost or any basis other than fair value (in millions).


		Fair Values as of February 2, 2014
		Portion of Carrying		Fair Value		Fair Value Measurement Using Significant Other Inputs (Level 2)		Fair Value Measurement
		Value Measured at Fair		Measurement Using				Using Unobservable Inputs
		Value		Quoted Prices				(Level 3)
				In Active Market
				For Identical
				Assets
				(Level 1)
	Assets:
	Trading securities (1)	$	14	$	14	$	—	$	—

	Investment funds — deferred compensation plan assets (1)	11		11		—		—

	Bank acceptances (1)	1		1		—		—

	Total assets measured at fair value	$	26	$	26	$	—	$	—

	Liabilities:
	Deferred compensation plan liabilities (2)	$	11	$	—	$	11	$	—

	_________________________________


	-1	Included in other current assets in our unaudited condensed consolidated balance sheet

	-2	Included in other current liabilities in our unaudited condensed consolidated balance sheet
	During the fiscal quarter ended February 2, 2014, there were no material transfers between Level 1, Level 2 or Level 3 fair value instruments.
	Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
	There were no non-financial assets or liabilities measured at fair value as of February 2, 2014.
	Fair Value of Other Financial Instruments
	The fair values of cash equivalents, trade accounts receivable, accounts payable and accrued liabilities, to the extent the underlying liability will be settled in cash, approximate carrying values because of the short-term nature of these instruments.

Shareholders_Equity

Shareholders' Equity	3 Months Ended
	Feb. 02, 2014
Equity [Abstract]	'
Shareholders' Equity	'
	Shareholders’ Equity
	Share Repurchase Program
	The Company repurchased 0.3 million shares for an aggregate purchase price of $12 million in cash at a weighted-average purchase price per share of $43.50 during the fiscal quarter ended February 2, 2014 under the 2013 share repurchase program. The 2013 share repurchase program will expire the day prior to the Company's 2014 annual general meeting, unless earlier terminated.
	Dividends
	We paid a cash dividend of $0.25 and $0.17 per share, or $62 million and $42 million in total, during the fiscal quarters ended February 2, 2014 and February 3, 2013, respectively.
	Share-Based Compensation Expense
	The following table summarizes share-based compensation expense related to share-based awards granted to employees, directors, and non-employees for the fiscal quarters ended February 2, 2014 and February 3, 2013 (in millions):


		Fiscal Quarter Ended
		February 2,				February 3,
		2014				2013
	Cost of products sold	$	3			$	2

	Research and development	8				7

	Selling, general and administrative	13				9

	Total share-based compensation expense	$	24			$	18

	The fair values of our time-based options and ESPP rights were estimated using the Black-Scholes option pricing model. Certain stock options granted in the fiscal quarter ended February 2, 2014 included both service and market conditions. The fair value of those market-based stock options was estimated using Monte Carlo simulation techniques.
	The weighted-average assumptions utilized for our time-based options, ESPP rights and market-based stock options granted during the fiscal quarters ended February 2, 2014 and February 3, 2013 were as follows:


		Time-based Options
		Fiscal Quarter Ended
		February 2,			February 3,
		2014			2013
	Risk-free interest rate	1.2	%		0.7	%
	Dividend yield	2	%		1.9	%
	Volatility	35	%		52	%
	Expected term (in years)	4.2			5



		ESPP Rights
		Fiscal Quarter Ended
		February 2,			February 3,
		2014			2013
	Risk-free interest rate	—	%		0.1	%
	Dividend yield	2.3	%		1.8	%
	Volatility	37	%		45	%
	Expected term (in years)	0.5			0.5



		Market-based Options
		Fiscal Quarter Ended
		February 2,
		2014
	Risk-free interest rate	2.4	%
	Dividend yield	1.9	%
	Volatility	46	%
	The dividend yields for the fiscal quarters ended February 2, 2014 and February 3, 2013 are based on the dividend yield as of the respective award grant dates. For the fiscal quarter ended February 2, 2014, expected volatility for time-based options is based on our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from our own traded shares with a term of 180 days measured at a specific date. Prior to fiscal year 2014, expected volatility was based on the combination of historical volatility of guideline publicly-traded companies and our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from traded options in guideline publicly-traded companies and our own shares with a term of 720 days or greater measured over the last three months.
	For the fiscal quarter ended February 2, 2014, market-based options expected volatility was based on the combination of historical volatility of guideline publicly-traded companies and our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from our own shares with a term of 180 days measured on date of grant. For the fiscal year ended November 3, 2013, market-based options expected volatility was based on the combination of historical volatility of guideline publicly-traded companies and our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from traded options in guideline publicly-traded companies and our own shares with a term of 720 days measured on date of grant.
	The risk-free interest rate is derived from the average U.S. Treasury Strips rate during the period, which approximates the rate in effect at the time of grant.
	For the fiscal quarter ended February 2, 2014, the expected term for time-based options was based on a weighted- average combining the average life of options that have already been exercised or cancelled with the expected life of all unexercised options. The expected life for unexercised options is calculated assuming that the options will be exercised at the midpoint of the vesting date (if unvested) or the valuation date (if vested) and the full contractual term. Our computations of expected term for time-based options prior to fiscal year 2014 were based on data, such as the data of peer companies and company-specific attributes, that we believe could affect employees’ exercise behavior.
	The expected life of market-based stock options valued using Monte Carlo simulation techniques is based upon the vesting dates forecasted by the simulation and then assuming that options which vest, and for which the market condition has been satisfied, are exercised at the midpoint between the forecasted vesting date and their expiration.
	Based on the above assumptions, the weighted-average fair values of the time-based options granted under the Company's equity incentive award plan for the fiscal quarters ended February 2, 2014 and February 3, 2013 were $11.57 and $13.32, respectively. The weighted-average fair value of the market-based options granted under the Company's equity incentive award plan for the fiscal quarter ended February 2, 2014 is $19.10. There were no market-based options granted for the fiscal quarter ended February 3, 2013.
	The weighted-average fair values of the rights to purchase shares in the ESPP for the fiscal quarters ended February 2, 2014 and February 3, 2013 were $12.16 and $11.54, respectively. The weighted-average fair values of RSUs granted in the fiscal quarters ended February 2, 2014 and February 3, 2013 were $46.60 and $34.83, respectively.
	Total compensation cost of time and market-based options granted but not yet vested as of February 2, 2014 was $165 million, which is expected to be recognized over the remaining weighted-average service period of 3 years. The total grant-date fair values of the time-based options vested during the fiscal quarters ended February 2, 2014 and February 3, 2013 were $10 million and $8 million, respectively. Total unrecognized compensation cost related to the ESPP rights as of February 2, 2014 was immaterial and is expected to be recognized over the remaining portion of the current offering period under the ESPP, which ends on March 14, 2014. Total compensation cost related to unvested RSUs as of February 2, 2014 was $38 million, which is expected to be recognized over the remaining weighted-average service period of 3 years. The total grant-date fair values of RSUs that vested during the fiscal quarter ended February 2, 2014 was $1 million. The total grant-date fair value of RSUs that vested during the fiscal quarter ended February 3, 2013 was immaterial.
	Equity Incentive Award Plans
	A summary of option award activity related to our equity incentive plans is as follows (in millions, except years and per share amounts):


				Option Awards Outstanding
	Shares			Number			Weighted-			Weighted-	Aggregate
	Available			Outstanding			Average			Average	Intrinsic
	for Grant						Exercise Price			Remaining	Value
							Per Share			Contractual
										Life (in years)
Balance as of November 3, 2013	10			22			$	29.81

Annual increase in shares available for issuance, per equity incentive plan terms	6

Granted	(1	)		1			50.08

Exercised	—			—			23.46

Cancelled	—			—			34.59

Balance as of February 2, 2014	15			23			31.21			5.57	$	531

Fully vested as of February 2, 2014				7			21.02			4.94	229

Fully vested and expected to vest as of
2-Feb-14				22			30.82			5.53	512

As of November 3, 2013, there were 10 million shares available for grant under the 2009 Equity Incentive Plan. Per the terms of the 2009 Equity Incentive Plan, an annual increase of 6 million shares was approved for issuance on the first day of fiscal year 2014. As of the quarter ended February 2, 2014, there were 15 million shares that remained available for grant.
The total intrinsic values of options exercised during the fiscal quarters ended February 2, 2014 and February 3, 2013 were $22 million and $25 million, respectively.
A summary of RSU activity related to our equity incentive plans is as follows (in millions, except years and per share amounts):


		RSU Awards Outstanding
		Number			Weighted-				Weighted-
		Outstanding			Average				Average
					Grant Date				Remaining
					Fair Market Value				Contractual
									Life (in years)
Balance as of November 3, 2013		2			$	34.38

Granted		—			46.6

Vested		—			34.86

Forfeited		—			38.37

Balance as of February 2, 2014		2			35.27				2.8

The following table summarizes the ranges of outstanding and exercisable option awards as of February 2, 2014 (in millions, except years and per share amounts):


		Option Awards Outstanding								Option Awards Exercisable
Exercise Prices		Number Outstanding			Weighted-		Weighted-Average			Number Exercisable		Weighted-Average
					Average		Exercise Price Per Share					Exercise Price Per Share
					Remaining
					Contractual
					Life (in years)
$0.00-$10.00		1			4.27		$	8.44		1		$	8.01

$10.01-$20.00		2			4.82		13.39			2		13.31

$20.01-$30.00		2			6.4		21.02			1		20.87

$30.01-$40.00		16			5.57		35.44			3		33.95

$40.01-$50.00		1			6.72		45.55			—		—

$50.01-$53.78		1			6.92		52.77			—		—

Total		23			5.57		31.21			7		21.02

Employee Share Purchase Plan
No shares were issued under the ESPP during the fiscal quarters ended February 2, 2014 and February 3, 2013. At February 2, 2014, 9.3 million shares remained available for issuance under the ESPP.

Income_Taxes

Income Taxes	3 Months Ended
Income Taxes	Feb. 02, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	For the fiscal quarter ended February 2, 2014, we recorded an income tax provision of $5 million, compared to $1 million for the fiscal quarter ended February 3, 2013. The increase in tax provision is primarily due to a change in the jurisdictional mix of income and expense. The tax expense for the fiscal quarter ended February 2, 2014 included a benefit of $4 million from the recognition of previously unrecognized tax benefits as a result of lapses in statutes of limitations. The tax expense for the fiscal quarter ended February 3, 2013 included a benefit of $3 million from U.S. legislation enacted in January 2, 2013 retroactively reinstating the research and development credit.
	Pursuant to Accounting Standards Codification (“ASC”) 740-10-25-3(e) (Income Taxes) and ASC 810-10-45-8 (Consolidation), during the fiscal quarter ended February 2, 2014, we recorded a deferred charge for the deferral of income tax expense on certain intercompany asset transactions that occurred in the fiscal quarter. The deferred charge of approximately $32 million, with $4 million included in other current assets and $28 million included in other long-term assets on our unaudited condensed consolidated balance sheets. The deferred charge will be amortized on a straight-line basis and will be included as a component of income tax expense over the life of the underlying assets, which has been estimated to be seven years.
	Unrecognized Tax Benefits
	As of November 3, 2013, the amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate was approximately $35 million, including accrued interest and penalties.
	We are subject to Singapore income tax examinations for the years ended October 31, 2006 and later, and in major jurisdictions outside Singapore for the years ended October 31, 2007 and later. However, we are not under Singapore income tax examination at this time. We believe it is possible that we may recognize $1 million to $13 million of our existing unrecognized tax benefits within the next 12 months as a result of lapses of statute of limitations for certain audit periods.

Segment_Information

Segment Information	3 Months Ended
Segment Information	Feb. 02, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	Segment Information
	ASC 280 “Segment Reporting,” or ASC 280, establishes standards for the way public business enterprises report information about operating segments in annual consolidated financial statements and requires that those enterprises report selected information about operating segments in interim financial reports. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers. We completed the CyOptics acquisition in the third quarter of fiscal year 2013 and have fully integrated CyOptics into Avago's organization structure and business model. Therefore, we have concluded that we continue to have one reportable segment based on the following factors: sales of semiconductors represents our only material source of revenue; substantially all products offered incorporate analog functionality and are manufactured under similar manufacturing processes; we use an integrated approach in developing our products in that discrete technologies developed are frequently integrated across many of our products; and we use a common order fulfillment process and similar distribution approach for our products. Broad distributor networks are typically used to distribute our products, with large accounts being serviced by a direct sales force. The Chief Executive Officer has been identified as the Chief Operating Decision Maker, as defined by ASC 280.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Feb. 02, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Related Party Transactions
	During the fiscal quarters ended February 2, 2014 and February 3, 2013, in the ordinary course of business, the Company purchased from, or sold to, several entities where one of the Company's directors also serves or served as a director or executive officer of that entity, including eSilicon Corporation (ceased to be a related party after the quarter ended May 5, 2013), KLA-Tencor Corporation and Wistron Corporation (ceased to be a related party after the quarter ended August 4, 2013). Management believes that such transactions are at arm's length and on similar terms as would have been obtained from unaffiliated third parties.
	The following tables provide information regarding the aggregate amounts involved in the transactions with these parties for the indicated periods (for the portion of such period that they were considered related) (in millions):


		Fiscal Quarter Ended
		February 2,			February 3,
		2014			2013
	Total net revenue (1) (2)	$	—	*	$	6

	Total costs and expenses (2)	—		*	1



		February 2,			November 3,
		2014			2013
	Total receivables	$	—	*	$	—	*

	Total payables	—		*	—		*

	_________________________________
	* Represent amounts less than $0.5 million.
	(1) Amounts include net revenue for related party transactions with Wistron Corporation through the fiscal quarter ended February 3, 2013. Wistron Corporation ceased to be a related party after the fiscal quarter ended August 4, 2013.
	(2) Amounts include net revenue, cost and expenses for related party transactions with eSilicon Corporation through the fiscal quarter ended February 3, 2013. eSilicon Corporation ceased to be a related party after the fiscal quarter May 5, 2013.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Feb. 02, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Commitments
	The following table sets forth changes in our commitments as of February 2, 2014 for the fiscal periods noted (in millions):


		Total		2014 (remainder)		2015		2016		2017		2018		2019		Thereafter
	Purchase Commitments	$	143	$	143	$	—	$	—	$	—	$	—	$	—	$	—

	Other Contractual Commitments	$	49	$	14	$	16	$	12	$	5	$	2	$	—	$	—

	Purchase Commitments. We have unconditional purchase obligations which include agreements to purchase goods or services that are enforceable and legally binding on us and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum or variable price provisions and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable without penalty.
	We also make purchases from a variety of vendors in connection with the expansion of our Fort Collins internal fabrication facility. These purchases are typically conducted on a purchase order basis and the purchase commitment amount shown in the table above includes $48 million in cancelable and non-cancelable outstanding purchase obligations under such purchase orders as of February 2, 2014.
	Other Contractual Commitments. Represents amounts payable pursuant to agreements related to outsourced IT, human resources, financial infrastructure outsourcing services and other services agreements.
	There were no other substantial changes to our contractual commitments during the first quarter of fiscal year 2014 from those disclosed in our Annual Report on Form 10-K for fiscal year 2013.
	Contingencies
	From time to time, we are involved in litigation that we believe is of the type common to companies engaged in our line of business, including commercial disputes, employment issues and disputes involving claims by third parties that our activities infringe their patent, copyright, trademark or other intellectual property rights. Legal proceedings are often complex, may require the expenditure of significant funds and other resources, and the outcome of litigation is inherently uncertain, with material adverse outcomes possible. Intellectual property claims generally involve the demand by a third-party that we cease the manufacture, use or sale of the allegedly infringing products, processes or technologies and/or pay substantial damages or royalties for past, present and future use of the allegedly infringing intellectual property. Claims that our products or processes infringe or misappropriate any third-party intellectual property rights (including claims arising through our contractual indemnification of our customers) often involve highly complex, technical issues, the outcome of which is inherently uncertain. Moreover, from time to time we pursue litigation to assert our intellectual property rights. Regardless of the merit or resolution of any such litigation, complex intellectual property litigation is generally costly and diverts the efforts and attention of our management and technical personnel.
	Lawsuits Relating to the Pending Acquisition of LSI
	Fifteen purported class action complaints have been filed by alleged stockholders of LSI against us. Eight of those lawsuits were filed in the Delaware Court of Chancery, and the other seven lawsuits were filed in the Superior Court of the State of California, County of Santa Clara on behalf of the same putative class as the Delaware actions. On January 17, 2014, the Delaware Court of Chancery entered an order consolidating the Delaware actions into a single action. These actions generally allege that we aided and abetted breaches of fiduciary duty by the members of LSI's board of directors in connection with the merger because the merger was not in the best interest of LSI, the merger consideration is unfair and certain other terms of the merger agreement are unfair. Among other remedies, the lawsuits seek to enjoin the merger, or in the event that an injunction is not entered and the merger closes, to rescind the merger or obtain unspecified money damages, costs and attorneys' fees.
	On March 7, 2014, the parties reached an agreement in principle to settle the consolidated Delaware action on a class wide basis, and negotiated a stipulation of settlement that was presented to the Delaware Court of Chancery on March 10, 2014. We and our board of directors believe these claims are entirely without merit and, in the event the settlement is not approved, we intend to vigorously defend these actions.
	Other Matters
	In addition to the matters discussed above, we are currently engaged in a number of legal actions in the ordinary course of our business.
	While there can be no assurance, we do not believe that we are involved in any pending legal proceedings that would be reasonably possible to have a material adverse effect on our financial condition, results of operations or cash flows. During the periods presented we have not recorded any accrual for loss contingencies associated with any legal proceedings nor determined that an unfavorable outcome is probable or reasonably possible. As a result, no amounts have been accrued or disclosed in the accompanying unaudited condensed consolidated financial statements with respect to these legal proceedings.
	Warranty
	There were no material changes to our warranty accrual during the fiscal quarter ended February 2, 2014.
	Indemnifications to Hewlett-Packard and Agilent
	Agilent, has given multiple indemnities to Hewlett-Packard Company in connection with its activities prior to its spin-off from Hewlett-Packard Company in June 1999 for the businesses that constituted Agilent prior to the spin-off. We are the successor to the SPG, of Agilent, which we acquired on December 1, 2005, which we refer to as the SPG Acquisition. As the successor to the SPG business of Agilent, we have acquired responsibility for indemnifications related to assigned intellectual property agreements. Additionally, when we completed the acquisition from Agilent in December 2005, we provided indemnities to Agilent with regard to Agilent’s conduct of the SPG business prior to the SPG Acquisition. In our opinion, the fair value of these indemnifications is not material and no amount has been accrued in the accompanying unaudited condensed consolidated financial statements with respect to these indemnification obligations.
	Other Indemnifications
	As is customary in our industry and as provided for in local law in the United States and other jurisdictions, many of our standard contracts provide remedies to our customers and others with whom we enter into contracts, such as defense, settlement, or payment of judgment for intellectual property claims related to the use of our products. From time to time, we indemnify customers, as well as our suppliers, contractors, lessors, lessees, companies that purchase our businesses or assets and others with whom we enter into contracts, against combinations of loss, expense, or liability arising from various triggering events related to the sale and the use of our products, the use of their goods and services, the use of facilities and state of our owned facilities, the state of the assets and businesses that we sell and other matters covered by such contracts, usually up to a specified maximum amount. In addition, from time to time we also provide protection to these parties against claims related to undiscovered liabilities, additional product liability or environmental obligations. In our experience, claims made under such indemnifications are rare and the associated estimated fair value of the liability is not material.

Restructuring_charges_Notes

Restructuring charges (Notes)	3 Months Ended
	Feb. 02, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Activities Disclosure [Text Block]	'
	Restructuring Charges
	In January 2014, we committed to a restructuring plan to close a fabrication facility as a result of the integration of the CyOptics business. The plan is expected to be substantially completed in the third quarter of fiscal year 2014. We recorded $8 million and $4 million in research and development expense and costs of products sold, respectively, during the quarter ended February 2, 2014, related to employment termination costs. As we previously effected a restructuring plan in the same location, for which similar termination packages were offered, we are therefore required to record the employment termination cost for the current restructuring plan in the period in which the plan was approved by our management in accordance with relevant accounting guidance. As of February 2, 2014, none of this charge has been paid and the remaining balance will be paid during fiscal year 2014 as the employees exit the Company. Other costs, including impairment of fixed assets and lease termination expenses of approximately $12 million, will be recorded in future quarters pursuant to the relevant accounting guidance. We also incurred restructuring charges of $5 million as a result of rationalizing research and development programs and continued alignment of our global manufacturing operations.
	The following table sets forth significant activities within and components of the restructuring charges during the first fiscal quarter of fiscal 2014 (in millions):


		Employee Termination Cost		Asset Abandonment Costs		Total
	Balance as of November 3, 2013	$	—	$	—	$	—

	Research and development	9		1		10

	Cost of product sold	5		—		5

	Operating expenses	2		—		2

	Less: Non-cash portion	—		1		1

	Less: Cash payments	2		—		2

	Accrued balance as of February 2, 2014 - included in Other current liabilities	$	14	$	—	$	14

Accumulated_Comprehensive_Inco

Accumulated Comprehensive Income (Loss)	3 Months Ended
	Feb. 02, 2014
Equity [Abstract]	'
Comprehensive Income (Loss) Note [Text Block]	'
	The change in accumulated other comprehensive income (loss) by component and related tax effects in the first quarter of fiscal 2014 is as follows (in millions):


		Prior Service Credits (Cost)			Actuarial Gains (Losses)			Total
	Balance as of November 3, 2013	$	(1	)	$	(5	)	$	(6	)
	Other comprehensive income (loss) before reclassifications	1			—			1

	Amounts reclassified out of accumulated other comprehensive loss	(1		)	(2		)	(3		)
	Tax effects	—			1			1

	Other comprehensive loss	—			(1		)	(1		)

	Balance as of February 2, 2014	$	(1	)	$	(6	)	$	(7	)
	The amounts reclassified out of accumulated other comprehensive income (loss) into the unaudited condensed consolidated statements of operations, with presentation location, during each period were as follows (in millions):


	Comprehensive Income Components		February 2,			February 3,			Classified to:
			2014			2013
	Post-retirement benefit amendment, curtailment and settlement gain, net		$	1		$	—		Cost of products sold

	Post-retirement benefit amendment, curtailment and settlement gain, net		1			—			Research and development

	Post-retirement benefit amendment, curtailment and settlement gain, net		1			—			Selling, general and administrative

	Total amounts reclassified out of accumulated other comprehensive income (loss)		$	3		$	—

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	'


	Comprehensive Income Components		February 2,			February 3,			Classified to:
			2014			2013
	Post-retirement benefit amendment, curtailment and settlement gain, net		$	1		$	—		Cost of products sold

	Post-retirement benefit amendment, curtailment and settlement gain, net		1			—			Research and development

	Post-retirement benefit amendment, curtailment and settlement gain, net		1			—			Selling, general and administrative

	Total amounts reclassified out of accumulated other comprehensive income (loss)		$	3		$	—

Subsequent_Events

Subsequent Events	3 Months Ended
Subsequent Events	Feb. 02, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Subsequent Event
	On March 5, 2014, the Board declared an interim cash dividend on the Company’s ordinary shares of $0.27 per share, payable on March 31, 2014 to shareholders of record at the close of business (5:00 p.m.), Eastern Time, on March 20, 2014.

Overview_and_Basis_of_Presenta1

Overview and Basis of Presentation (Policies)	3 Months Ended
Overview and Basis of Presentation (Policies)	Feb. 02, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Cash Flow, Supplemental Disclosures [Text Block]	'
Cash Flow, Supplemental Disclosures [Text Block]	Supplemental cash flow disclosures. At February 2, 2014 and November 3, 2013, we had $34 million and $31 million, respectively, of unpaid purchases of property, plant, and equipment included in accounts payable and other current liabilities. Amounts reported as unpaid purchases will be recorded as cash outflows from investing activities for purchases of property, plant, and equipment in the unaudited condensed consolidated statement of cash flows for the period in which they are paid.
Fiscal Periods	'
Fiscal Periods	Fiscal Periods. We operate on a 52- or 53-week fiscal year ending on the Sunday closest to October 31. Our fiscal year ending November 2, 2014, or fiscal year 2014, is a 52-week fiscal year. The first quarter of our fiscal year 2014 ended on February 2, 2014, the second quarter will end on May 4, 2014, the third quarter will end on August 3, 2014 and the fourth quarter will end on November 2, 2014.
Information	'
	Information. The unaudited condensed consolidated financial statements include the accounts of Avago Technologies Limited and all of its wholly-owned subsidiaries, and are prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP. Intercompany transactions and balances have been eliminated in consolidation.
	During fiscal year 2013, we completed our acquisition of CyOptics, Inc., or CyOptics. The unaudited condensed consolidated financial statements include the results of operations of CyOptics commencing as of the closing date of the acquisition. (See Note 3. "Acquisitions")
	Interim information presented in the unaudited condensed consolidated financial statements has been prepared by management and, in the opinion of management, includes all adjustments of a normal recurring nature that are necessary for the fair statement of the financial position, results of operations, comprehensive income and cash flows for the periods shown, and is in accordance with GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the fiscal year ended November 3, 2013, or fiscal year 2013, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on December 20, 2013.
	The operating results for the fiscal quarter ended February 2, 2014 are not necessarily indicative of the results that may be expected for fiscal year 2014, or for any other future period. The balance sheet data as of November 3, 2013 presented are derived from the audited consolidated financial statements as of that date.
Use of estimates	'
Use of estimates	Use of estimates. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods.
Concentration Risk and Significant Customers, Policy [Policy Text Block]	'
	Concentrations of credit risk and significant customers. Our cash, cash equivalents and accounts receivable are potentially subject to concentration of credit risk. Cash and cash equivalents may be redeemable upon demand and are maintained with several financial institutions that management believes are of high credit quality and therefore bear minimal credit risk. We seek to mitigate our credit risks by spreading such risks across multiple counterparties and monitoring the risk profile of these counterparties. Our accounts receivable are derived from revenue earned from customers located in the U.S. and internationally. We mitigate collection risks from our customers by performing regular credit evaluations of our customers' financial conditions, and require collateral, such as letters of credit and bank guarantees, in certain circumstances.
	We sell our products through our direct sales force, distributors and manufacturers' representatives. One direct customer accounted for 26% of our net accounts receivable balance at both February 2, 2014 and November 3, 2013. For the fiscal quarter ended February 2, 2014, one direct customer represented 25% of our net revenue. For the fiscal quarter ended February 3, 2013, one direct customer represented 21% of our net revenue.
Standard Product Warranty, Policy [Policy Text Block]	'
Standard Product Warranty, Policy [Policy Text Block]	Warranty. We accrue for the estimated costs of product warranties at the time revenue is recognized. Product warranty costs are estimated based upon our historical experience and specific identification of product requirements, which may fluctuate based on product mix. Additionally, we accrue for warranty costs associated with occasional or unanticipated product quality issues if a loss is probable and can be reasonably estimated. Warranty costs were not material for either of the fiscal quarters ended February 2, 2014 or February 3, 2013.
Net income per share	'
	Net income per share. Basic net income per share is computed using the weighted-average number of ordinary shares outstanding during the period. Diluted net income per share is computed using the weighted-average number of ordinary shares and potentially dilutive share equivalents outstanding during the period. Diluted shares outstanding includes the dilutive effect of in-the-money options (including market-based share options), restricted share units, or RSUs, and employee share purchase rights under the Avago Technologies Limited Employee Share Purchase Plan, or ESPP. The dilutive effect of such equity awards is calculated based on the average share price for each fiscal period, using the treasury stock method. Under the treasury stock method, the amount the employee must pay for exercising share options and to purchase shares under the ESPP, the amount of compensation cost for future service that the Company has not yet recognized, and the amount of tax benefits that would be recorded in an ordinary shares account when equity awards become deductible for income tax purposes are collectively assumed to be used to repurchase ordinary shares.
	Diluted net income per share for the fiscal quarter ended February 2, 2014 and the fiscal quarter ended February 3, 2013 excluded the potentially dilutive effect of weighted-average outstanding equity awards (options, RSUs and ESPP rights) to acquire 1 million and 2 million ordinary shares respectively, as their effect was antidilutive.
Segment Reporting	'
Segment Reporting	ASC 280 “Segment Reporting,” or ASC 280, establishes standards for the way public business enterprises report information about operating segments in annual consolidated financial statements and requires that those enterprises report selected information about operating segments in interim financial reports. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers.
Recent Accounting Guidance	'
	Recently Adopted Accounting Guidance
	In the first quarter of fiscal year 2014, we adopted guidance issued by the Financial Accounting Standards Board, or FASB, relating to reporting on reclassifications out of accumulated other comprehensive income (loss). This guidance seeks to improve the reporting of such reclassifications by requiring an entity to report the effect of significant reclassifications out of accumulated other comprehensive income (loss) on the respective line items in net income if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under GAAP that provide additional detail about those amounts. The amendments in this guidance supersede the presentation requirements for reclassifications out of accumulated other comprehensive income (loss) in previously issued guidance. The adoption of this guidance affected the presentation of comprehensive income, but did not have any impact our financial condition or results of operations.
	Recent Accounting Guidance Not Yet Adopted
	In July 2013, the FASB issued an amendment to the accounting guidance related to the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. The guidance requires an unrecognized tax benefit to be presented as a decrease in a deferred tax asset where a net operating loss, a similar tax loss or a tax credit carryforward exists and certain criteria are met. This guidance will be effective for the first quarter of our fiscal year 2015. The adoption of this guidance will affect the presentation of our unrecognized tax benefits but will not impact the Company's financial condition or results of operations.

Overview_and_Basis_of_Presenta2

Overview and Basis of Presentation (Tables)	3 Months Ended
	Feb. 02, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Reconciliation of the denominators of the basic and diluted net income per share	'
	The following is a reconciliation of the basic and diluted net income per share computations for the periods presented (in millions, except per share data):


		Fiscal Quarter Ended
		February 2,		February 3,
		2014		2013
	Net income (Numerator):
	Net income	$	134	$	125

	Shares (Denominator):
	Basic weighted-average ordinary shares outstanding	249		246

	Add incremental shares for:
	Dilutive effect of share options, RSUs and ESPP rights	6		5

	Shares used in diluted computation	255		251

	Net income per share:
	Basic	$	0.54	$	0.51

	Diluted	$	0.53	$	0.5

Inventory_Tables

Inventory (Tables)	3 Months Ended
	Feb. 02, 2014
Inventory Disclosure [Abstract]	'
Summary of inventory	'
	Inventory consists of the following (in millions):


		February 2,		November 3,
		2014		2013
	Finished goods	$	56	$	53

	Work-in-process	146		154

	Raw materials	84		78

	Total inventory	$	286	$	285

Acquisitions_Acquisitions_Tabl

Acquisitions Acquisitions (Tables)	3 Months Ended
	Feb. 02, 2014
Business Combinations [Abstract]	'
Business Acquisition, Pro Forma Information [Table Text Block]	'


		Fiscal Year Ended
		3-Nov-13				28-Oct-12
	Pro forma net revenue	$	2,663			$	2,578

	Pro forma net income	$	547			$	551

	Pro forma net income per share-basic	$	2.21			$	2.25

	Pro forma net income per share-diluted	$	2.17			$	2.2

Schedule of Purchase Price Allocation [Table Text Block]	'
	Our preliminary allocation of the total purchase price for CyOptics and the purchased intangible assets as of February 2, 2014 is as follows (in millions):


		Estimated Fair Value
	Trade accounts receivable	$	51

	Inventory	35

	Other current assets	2

	Property, plant and equipment	44

	Goodwill	190

	Intangible assets	141

	Total assets acquired	463

	Accounts payable	(25		)
	Employee compensation and benefits	(5		)
	Other current liabilities	(2		)
	Long-term deferred tax liabilities (included in Other long-term liabilities)	(54		)
	Total liabilities assumed	(86		)
	Purchase price allocation	$	377

Schedule of Finite and Indefinite Lived Intangible Assets Acquired as part of Business Combination [Table Text Block]	'


		Estimated Fair Value			Estimated Useful
		(in millions)			Lives (in years)
	Purchased intangible assets
	Purchased technology - base product	$	98		8

	Purchased technology - packaging	3			5

	Customer relationships	32			7

	Other - customer backlog	4			1

	Total identified intangible finite lived assets	137

	In process research and development indefinite lived assets	4

	Total identified intangible assets	$	141

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Feb. 02, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Intangible assets	'
	Purchased intangibles consist of the following (in millions):


		Gross Carrying		Accumulated			Net Book Value
		Amount		Amortization
	As of February 2, 2014:
	Purchased technology	$	843	$	(480	)	$	363

	Customer and distributor relationships	289		(192		)	97

	Other	8		(5		)	3

	Intangible assets subject to amortization	1,140		(677		)	463

	In-process research and development	4		—			4

	Total	$	1,144	$	(677	)	$	467


	As of November 3, 2013:
	Purchased technology	$	843	$	(462	)	$	381

	Customer and distributor relationships	289		(186		)	103

	Other	8		(4		)	4

	Intangible assets subject to amortization	1,140		(652		)	488

	In-process research and development	4		—			4

	Total	$	1,144	$	(652	)	$	492

Amortization of purchased intangible assets	'
	The following table presents the amortization expense of purchased intangible assets (in millions):


		Fiscal Quarter Ended
		February 2,		February 3,
		2014		2013
	Cost of products sold	$	18	$	14

	Operating expenses	7		5

	Total amortization expense	$	25	$	19

Weighted-average amortization periods	'
	The weighted-average amortization periods remaining by intangible asset category at February 2, 2014 were as follows (in years):


	Amortizable intangible assets:
	Purchased technology	7
	Customer and distributor relationships	6
	Other	9
	Based on the amount of intangible assets subject to amortization at February 2, 2014, the expected amortization expense for each of the next five fiscal years and thereafter is as follows (in millions):


	Fiscal Year	Amount
	2014 (remainder)	$	74

	2015	95

	2016	78

	2017	68

	2018	33

	2019	29

	Thereafter	86

		$	463

Fair_Value_Tables

Fair Value (Tables)	3 Months Ended
	Feb. 02, 2014
Fair Value Disclosures [Abstract]	'
Financial assets measured at fair value on a recurring basis	'
	The table below sets forth by level our financial assets and liabilities that were accounted for at fair value as of February 2, 2014. The table does not include cash on hand and also does not include assets that are measured at historical cost or any basis other than fair value (in millions).


		Fair Values as of February 2, 2014
		Portion of Carrying		Fair Value		Fair Value Measurement Using Significant Other Inputs (Level 2)		Fair Value Measurement
		Value Measured at Fair		Measurement Using				Using Unobservable Inputs
		Value		Quoted Prices				(Level 3)
				In Active Market
				For Identical
				Assets
				(Level 1)
	Assets:
	Trading securities (1)	$	14	$	14	$	—	$	—

	Investment funds — deferred compensation plan assets (1)	11		11		—		—

	Bank acceptances (1)	1		1		—		—

	Total assets measured at fair value	$	26	$	26	$	—	$	—

	Liabilities:
	Deferred compensation plan liabilities (2)	$	11	$	—	$	11	$	—

	_________________________________


	-1	Included in other current assets in our unaudited condensed consolidated balance sheet

	-2	Included in other current liabilities in our unaudited condensed consolidated balance shee

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	3 Months Ended
	Feb. 02, 2014
Equity [Abstract]	'
Summary of share-based compensation expense related to share-based awards granted to employees, directors, and non-employees	'
	The following table summarizes share-based compensation expense related to share-based awards granted to employees, directors, and non-employees for the fiscal quarters ended February 2, 2014 and February 3, 2013 (in millions):


		Fiscal Quarter Ended
		February 2,			February 3,
		2014			2013
	Cost of products sold	$	3		$	2

	Research and development	8			7

	Selling, general and administrative	13			9

	Total share-based compensation expense	$	24		$	18

Weighted average assumptions of stock options	'
	The fair values of our time-based options and ESPP rights were estimated using the Black-Scholes option pricing model. Certain stock options granted in the fiscal quarter ended February 2, 2014 included both service and market conditions. The fair value of those market-based stock options was estimated using Monte Carlo simulation techniques.
	The weighted-average assumptions utilized for our time-based options, ESPP rights and market-based stock options granted during the fiscal quarters ended February 2, 2014 and February 3, 2013 were as follows:


		Time-based Options
		Fiscal Quarter Ended
		February 2,		February 3,
		2014		2013
	Risk-free interest rate	1.2	%	0.7	%
	Dividend yield	2	%	1.9	%
	Volatility	35	%	52	%
	Expected term (in years)	4.2		5



		Market-based Options
		Fiscal Quarter Ended
		February 2,
		2014
	Risk-free interest rate	2.4	%
	Dividend yield	1.9	%
	Volatility	46	%
Weighted average assumptions of employee share purchase plan	'


		ESPP Rights
		Fiscal Quarter Ended
		February 2,		February 3,
		2014		2013
	Risk-free interest rate	—	%	0.1	%
	Dividend yield	2.3	%	1.8	%
	Volatility	37	%	45	%
	Expected term (in years)	0.5		0.5

Summary of share based payment award activity	'
	A summary of option award activity related to our equity incentive plans is as follows (in millions, except years and per share amounts):


				Option Awards Outstanding
		Shares		Number			Weighted-			Weighted-	Aggregate
		Available		Outstanding			Average			Average	Intrinsic
		for Grant					Exercise Price			Remaining	Value
							Per Share			Contractual
										Life (in years)
	Balance as of November 3, 2013	10		22			$	29.81

	Annual increase in shares available for issuance, per equity incentive plan terms	6

	Granted	(1	)	1			50.08

	Exercised	—		—			23.46

	Cancelled	—		—			34.59

	Balance as of February 2, 2014	15		23			31.21			5.57	$	531

	Fully vested as of February 2, 2014			7			21.02			4.94	229

	Fully vested and expected to vest as of
	2-Feb-14			22			30.82			5.53	512

Ranges of outstanding and exercisable awards	'
	The following table summarizes the ranges of outstanding and exercisable option awards as of February 2, 2014 (in millions, except years and per share amounts):


			Option Awards Outstanding							Option Awards Exercisable
	Exercise Prices		Number Outstanding		Weighted-		Weighted-Average			Number Exercisable		Weighted-Average
					Average		Exercise Price Per Share					Exercise Price Per Share
					Remaining
					Contractual
					Life (in years)
	$0.00-$10.00		1		4.27		$	8.44		1		$	8.01

	$10.01-$20.00		2		4.82		13.39			2		13.31

	$20.01-$30.00		2		6.4		21.02			1		20.87

	$30.01-$40.00		16		5.57		35.44			3		33.95

	$40.01-$50.00		1		6.72		45.55			—		—

	$50.01-$53.78		1		6.92		52.77			—		—

	Total		23		5.57		31.21			7		21.02

Schedule of Other Share-based Compensation, Activity [Table Text Block]	'
	A summary of RSU activity related to our equity incentive plans is as follows (in millions, except years and per share amounts):


			RSU Awards Outstanding
			Number		Weighted-				Weighted-
			Outstanding		Average				Average
					Grant Date				Remaining
					Fair Market Value				Contractual
									Life (in years)
	Balance as of November 3, 2013		2		$	34.38

	Granted		—		46.6

	Vested		—		34.86

	Forfeited		—		38.37

	Balance as of February 2, 2014		2		35.27				2.8

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	3 Months Ended
	Feb. 02, 2014
Related Party Transactions [Abstract]	'
Transactions and balances with related parties	'


		Fiscal Quarter Ended
		February 2,			February 3,
		2014			2013
	Total net revenue (1) (2)	$	—	*	$	6

	Total costs and expenses (2)	—		*	1



		February 2,			November 3,
		2014			2013
	Total receivables	$	—	*	$	—	*

	Total payables	—		*	—		*

	_________________________________
	* Represent amounts less than $0.5 million.
	(1) Amounts include net revenue for related party transactions with Wistron Corporation through the fiscal quarter ended February 3, 2013. Wistron Corporation ceased to be a related party after the fiscal quarter ended August 4, 2013.
	(2) Amounts include net revenue, cost and expenses for related party transactions with eSilicon Corporation through the fiscal quarter ended February 3, 2013. eSilicon Corporation ceased to be a related party after the fiscal quarter May 5, 2013.

Commitments_And_Contingencies_

Commitments And Contingencies (Tables)	3 Months Ended
	Feb. 02, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Changes in commitments	'
	The following table sets forth changes in our commitments as of February 2, 2014 for the fiscal periods noted (in millions):


		Total		2014 (remainder)		2015		2016		2017		2018		2019		Thereafter
	Purchase Commitments	$	143	$	143	$	—	$	—	$	—	$	—	$	—	$	—

	Other Contractual Commitments	$	49	$	14	$	16	$	12	$	5	$	2	$	—	$	—

Restructuring_charges_Tables

Restructuring charges (Tables)	3 Months Ended
	Feb. 02, 2014
Restructuring and Related Activities [Abstract]	'
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	'


		Employee Termination Cost		Asset Abandonment Costs		Total
	Balance as of November 3, 2013	$	—	$	—	$	—

	Research and development	9		1		10

	Cost of product sold	5		—		5

	Operating expenses	2		—		2

	Less: Non-cash portion	—		1		1

	Less: Cash payments	2		—		2

	Accrued balance as of February 2, 2014 - included in Other current liabilities	$	14	$	—	$	14

Accumulated_Comprehensive_Inco1

Accumulated Comprehensive Income (Loss) (Tables)	3 Months Ended
	Feb. 02, 2014
Equity [Abstract]	'
Comprehensive Income (Loss) Note [Text Block]	'
	The change in accumulated other comprehensive income (loss) by component and related tax effects in the first quarter of fiscal 2014 is as follows (in millions):


		Prior Service Credits (Cost)			Actuarial Gains (Losses)			Total
	Balance as of November 3, 2013	$	(1	)	$	(5	)	$	(6	)
	Other comprehensive income (loss) before reclassifications	1			—			1

	Amounts reclassified out of accumulated other comprehensive loss	(1		)	(2		)	(3		)
	Tax effects	—			1			1

	Other comprehensive loss	—			(1		)	(1		)

	Balance as of February 2, 2014	$	(1	)	$	(6	)	$	(7	)
	The amounts reclassified out of accumulated other comprehensive income (loss) into the unaudited condensed consolidated statements of operations, with presentation location, during each period were as follows (in millions):


	Comprehensive Income Components		February 2,			February 3,			Classified to:
			2014			2013
	Post-retirement benefit amendment, curtailment and settlement gain, net		$	1		$	—		Cost of products sold

	Post-retirement benefit amendment, curtailment and settlement gain, net		1			—			Research and development

	Post-retirement benefit amendment, curtailment and settlement gain, net		1			—			Selling, general and administrative

	Total amounts reclassified out of accumulated other comprehensive income (loss)		$	3		$	—

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	'


	Comprehensive Income Components		February 2,			February 3,			Classified to:
			2014			2013
	Post-retirement benefit amendment, curtailment and settlement gain, net		$	1		$	—		Cost of products sold

	Post-retirement benefit amendment, curtailment and settlement gain, net		1			—			Research and development

	Post-retirement benefit amendment, curtailment and settlement gain, net		1			—			Selling, general and administrative

	Total amounts reclassified out of accumulated other comprehensive income (loss)		$	3		$	—

Overview_and_Basis_of_Presenta3

Overview and Basis of Presentation (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1	2
Net income (Numerator):	'	'
Net income	$134	$125
Shares (Denominator):	'	'
Basic weighted average ordinary shares outstanding	249	246
Add: Incremental shares for:	'	'
Dilutive effect of share options, RSUs and ESPP rights	6	5
Shares used in diluted computation	255	251
Net income per share:	'	'
Basic	$0.54	$0.51
Diluted	$0.53	$0.50

Overview_and_Basis_of_Presenta4

Overview and Basis of Presentation (Details Textuals) (USD $)	3 Months Ended		12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Feb. 02, 2014	Nov. 03, 2013	Nov. 03, 2013	Feb. 02, 2014	Nov. 03, 2013	Feb. 02, 2014	Nov. 03, 2013	Feb. 02, 2014	Feb. 03, 2013	Feb. 02, 2014	Feb. 03, 2013
				Net accounts receivable [Member]	Net accounts receivable [Member]	Net accounts receivable [Member]	Net accounts receivable [Member]	Sales [Member]	Sales [Member]	Sales [Member]	Sales [Member]
				Customer	Customer	Major Customer One [Member]	Major Customer One [Member]	Customer	Customer	Major Customer One [Member]	Major Customer One [Member]
Capital Expenditures Incurred but Not yet Paid	$34	$31	'	'	'	'	'	'	'	'	'
Fiscal period end	'364 days	'	'371 days	'	'	'	'	'	'	'	'
Number of customers accounted for 10% or more of net accounts receivable balance	'	'	'	1	1	'	'	1	1	'	'
Concentration Risk, Percentage	'	'	'	'	'	26.00%	26.00%	'	'	25.00%	21.00%

Inventory_Details

Inventory (Details) (USD $)	Feb. 02, 2014	Nov. 03, 2013
In Millions, unless otherwise specified	Feb. 02, 2014	Nov. 03, 2013
Inventory Disclosure [Abstract]	'	'
Finished goods	$56	$53
Work-in-process	146	154
Raw materials	84	78
Total inventory	$286	$285	[1]

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Acquisitions_Pending_Acqusitio

Acquisitions Pending Acqusition - LSI Corporation (Details) (LSI acquisition [Member], USD $)	1 Months Ended
	Dec. 15, 2013
Business Acquisition [Line Items]	'
Purchase price related to LSI acquisition	$6,600,000,000
Business Acquisition, Share Price	$11.15
Termination Fee Receivable	200,000,000
Termination Fee Payable	400,000,000
Business Acquisition expected financing cash portion	1,000,000,000
Business Acquisition expected financing through term loans	4,600,000,000
Proceeds from Convertible Debt	1,000,000,000
Business Acquisition-Cash from conv senior notes	1,000
Debt Conversion, Converted Instrument, Shares Issued	20.816
Debt Instrument, Convertible, Conversion Price	$48.04
Convertible Debt [Member]	'
Business Acquisition [Line Items]	'
Debt Instrument, Interest Rate, Stated Percentage	2.00%
Revolving Credit Facility [Member]	'
Business Acquisition [Line Items]	'
Line of Credit Facility, Remaining Borrowing Capacity	$500,000,000

Acquisition_Details_CyOptics_T

Acquisition (Details) CyOptics Textuals (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Feb. 02, 2014

Feb. 03, 2013

Nov. 03, 2013

Feb. 02, 2014

Nov. 03, 2013

Order or Production Backlog [Member]

Customer Relationships [Member]

Purchased Technology - Packaging [Member]

Purchased Technology - Base Product [Member]

CyOptics Mexico [Member]

CyOptics [Member]

Minimum [Member]

employees

Purchased Technology - Base Product [Member]

CyOptics [Member]

Business Acquisition [Line Items]

Total Acquired Employees

745

1,100

Business Combination, Consideration Transferred

$377

Working Capital Adjustment, Cash Paid

Acquisitions, net of cash acquired

373

Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents

Business Acquisition, Contingent Consideration, Potential Cash Payment

Business Acquisition, Management Retention Bonus Prepayment

Business Acquisition, Management Retention Bonus Compensation

Acquired Finite-lived Intangible Asset, Amount

Business Acquisition, Purchase Price Allocation, Assets Acquired

463

Amortization of useful life of acquired intangible assets, minimum (in years)

'1 year

'7 years

'5 years

'8 years

'1 year

Business Combination, Property, Plant, and Equipment Increase

Deferred Tax Liabilities, Property, Plant and Equipment

Deferred Tax Liabilities, Other

Goodwill, Purchase Accounting Adjustments

Acquisitions_Acquisition_CyOpt

Acquisitions Acquisition - CyOptics (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Nov. 03, 2013		Feb. 02, 2014
Business Acquisition [Line Items]	'		'
Employee-related Liabilities, Current	($98)	[1]	($59)
Purchased Technology - Base Product [Member]	'		'
Business Acquisition [Line Items]	'		'
Acquired Finite-lived Intangible Asset, Amount	98		'
Finite-Lived Intangible Asset, Useful Life	'8 years		'
Purchased Technology - Packaging [Member]	'		'
Business Acquisition [Line Items]	'		'
Acquired Finite-lived Intangible Asset, Amount	3		'
Finite-Lived Intangible Asset, Useful Life	'5 years		'
Customer Relationships [Member]	'		'
Business Acquisition [Line Items]	'		'
Acquired Finite-lived Intangible Asset, Amount	32		'
Finite-Lived Intangible Asset, Useful Life	'7 years		'
Order or Production Backlog [Member]	'		'
Business Acquisition [Line Items]	'		'
Acquired Finite-lived Intangible Asset, Amount	4		'
Finite-Lived Intangible Asset, Useful Life	'1 year		'
CyOptics [Member]	'		'
Business Acquisition [Line Items]	'		'
Acquired Finite-lived Intangible Asset, Amount	137		'
CyOptics [Member]	'		'
Business Acquisition [Line Items]	'		'
Acquired Indefinite-lived Intangible Asset, Amount	4		'
CyOptics [Member]	'		'
Business Acquisition [Line Items]	'		'
Business Combination, Indemnification Assets, Amount as of Acquisition Date	'		12
Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents	3		'
Business Acquisition, Purchase Price Allocation, Current Assets, Receivables	51		'
Business Acquisition, Purchase Price Allocation, Current Assets, Inventory	35		'
Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets	2		'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	44		'
Business Acquisition, Purchase Price Allocation, Goodwill Amount	190		'
Acquired Finite-lived Intangible Asset, Amount	141		'
Business Acquisition, Purchase Price Allocation, Assets Acquired	463		'
Business Acquisition, Purchase Price Allocation, Current Liabilities, Accounts Payable	-25		'
Employee-related Liabilities, Current	-5		'
Business Acquisition, Purchase Price Allocation, Current Liabilities	-2		'
Business Acquisition, Purchase Price Allocation, Deferred Tax Liabilities, Noncurrent	-54		'
Business Acquisition, Purchase Price Allocation, Liabilities Assumed	-86		'
Business Combination, Consideration Transferred	$377		'
CyOptics [Member] \| Purchased Technology - Base Product [Member]	'		'
Business Acquisition [Line Items]	'		'
Finite-Lived Intangible Asset, Useful Life	'8 years		'

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Acquisitions_Aquisition_CyOpti

Acquisitions Aquisition - CyOptics Pro Forma (Details) (CyOptics [Member], USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Nov. 03, 2013	Oct. 28, 2012
CyOptics [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Acquisition, Pro Forma Revenue	$2,663	$2,578
Business Acquisition, Pro Forma Net Income (Loss)	$547	$551
Business Acquisition, Pro Forma Earnings Per Share, Basic	$2.21	$2.25
Business Acquisition, Pro Forma Earnings Per Share, Diluted	$2.17	$2.20

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets Goodwill and Intangible Assets (Details) (USD $)	Feb. 02, 2014	Nov. 03, 2013
In Millions, unless otherwise specified	Feb. 02, 2014	Nov. 03, 2013
Goodwill [Roll Forward]	'	'
Balance as of November 3, 2013	$392	$391	[1]
Balance as of February 2, 2014	$392	$391	[1]

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets (Details 1) (USD $)	Feb. 02, 2014	Nov. 03, 2013
In Millions, unless otherwise specified	Feb. 02, 2014	Nov. 03, 2013
Finite Lived Intangible Assets Net [Abstract]	'	'
Intangible assets, Gross Carrying Amount	$1,140	$1,140
Intangible assets, Accumulated Amortization	-677	-652
Intangible assets, Net Book Value	463	488
Intangible Assets, Net Excluding Goodwill	467	492	[1]
Gross Intangible Assets Excluding Goodwill	1,144	1,144
In-process Research and Development [Member]	'	'
Finite Lived Intangible Assets Net [Abstract]	'	'
Indefinite-Lived Intangible Assets (Excluding Goodwill)	4	4
Technology-Based Intangible Assets [Member]	'	'
Finite Lived Intangible Assets Net [Abstract]	'	'
Intangible assets, Gross Carrying Amount	843	843
Intangible assets, Accumulated Amortization	-480	-462
Intangible assets, Net Book Value	363	381
Customer And Distributor Relationships [Member]	'	'
Finite Lived Intangible Assets Net [Abstract]	'	'
Intangible assets, Gross Carrying Amount	289	289
Intangible assets, Accumulated Amortization	-192	-186
Intangible assets, Net Book Value	97	103
Other Intangible Assets [Member]	'	'
Finite Lived Intangible Assets Net [Abstract]	'	'
Intangible assets, Gross Carrying Amount	8	8
Intangible assets, Accumulated Amortization	-5	-4
Intangible assets, Net Book Value	$3	$4

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Recovered_Sheet1

Goodwill And Intangible Assets (Details 2) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013
Amortization of purchased intangible assets	'	'
Amortization of intangible assets	$7	$5
Total Amortization	25	19
Cost of Products Sold [Member]	'	'
Amortization of purchased intangible assets	'	'
Amortization of intangible assets	18	14
Operating Expenses [Member]	'	'
Amortization of purchased intangible assets	'	'
Amortization of intangible assets	$7	$5

Goodwill_and_Intangible_Assets4

Goodwill and Intangible Assets (Details 3) (USD $)	Feb. 02, 2014	Nov. 03, 2013
In Millions, unless otherwise specified	Feb. 02, 2014	Nov. 03, 2013
Finite lived intangible assets future amortization expense	'	'
Amortization, 2014 (remainder)	$74	'
Amortization, 2015	95	'
Amortization, 2016	78	'
Amortization, 2017	68	'
Amortization, 2018	33	'
Amortization, 2019	29	'
Amortization, Thereafter	86	'
Intangible assets, Net Book Value	$463	$488

Goodwill_and_Intangible_Assets5

Goodwill and Intangible Assets (Details 4)	3 Months Ended
Goodwill and Intangible Assets (Details 4)	Feb. 02, 2014
Technology-Based Intangible Assets [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'7 years
Customer Relationships [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'6 years
Other Intangible Assets [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'9 years

Retirement_Plans_and_PostRetir1

Retirement Plans and Post-Retirement Benefits (Details) (USD $)	3 Months Ended
	Feb. 02, 2014
Defined Benefit Plan Disclosure [Line Items]	'
Payments to Employees	$6,000,000
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]	'
Curtailment gain	1,000,000
Settlement Gain	2,000,000
Restructuring and Related Cost, Expected Cost	12,000,000
U.S. Post-Retirement Medical Benefit Plan [Member]	'
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]	'
Pension and Other Postretirement Defined Benefit Plans, Liabilities	14,000,000
Retiree medical account program, spending account $55,000 [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
Postretirement medical account program, spending account, amount	55,000
Retiree medical account program, spending account of $40,000 [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
Postretirement medical account program, spending account, amount	$40,000

Borrowings_Details

Borrowings (Details) (USD $)	Feb. 02, 2014	Nov. 03, 2013
Debt Instrument [Line Items]	'	'
Line of Credit Facility, Amount Outstanding	$0	$0
Debt Issuance Cost	$2,000,000	'

Fair_Value_Details

Fair Value (Details) (Fair Value, Measurements, Recurring [Member], USD $)	Feb. 02, 2014
In Millions, unless otherwise specified	Feb. 02, 2014
Portion of Carrying Value Measured at Fair Value [Member]	'
Liabilities	'
Liabilities measured at fair value	$11	[1]
Fair Value Measurement Using Quoted Prices In Active Market For Identical Assets (Level 1) [Member]	'
Assets	'
Trading securities	14	[2]
Deferred Compensation Plan Assets	11	[2]
Bank acceptances	1	[2]
Assets measured at fair value	26
Liabilities	'
Liabilities measured at fair value	0
Fair Value Measurement Using Significant Other Inputs [Member]	'
Assets	'
Trading securities	0
Deferred Compensation Plan Assets	0
Bank acceptances	0
Assets measured at fair value	0
Liabilities	'
Liabilities measured at fair value	11	[1]
Fair Value Measurement Using Unobservable Inputs	'
Assets	'
Trading securities	0
Deferred Compensation Plan Assets	0
Bank acceptances	0
Assets measured at fair value	0
Liabilities	'
Liabilities measured at fair value	$0

[1]	Included in other current liabilities in our unaudited condensed consolidated balance shee
[2]	Included in other current assets in our unaudited condensed consolidated balance sheet

Fair_Value_Details_Textuals

Fair Value (Details Textuals) (USD $)	Feb. 02, 2014
In Millions, unless otherwise specified	Feb. 02, 2014
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available-for-sale Securities	$14	[1]
Fair Value (Textuals) [Abstract]	'
Non-financial assets measured at fair value	26
Non-financial liabilities measured at fair value	0
Fair Value, Measurements, Recurring [Member] \| Fair Value Measurement Using Unobservable Inputs	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Available-for-sale Securities	0
Fair Value (Textuals) [Abstract]	'
Non-financial assets measured at fair value	0
Non-financial liabilities measured at fair value	0
Fair Value, Measurements, Nonrecurring [Member]	'
Fair Value (Textuals) [Abstract]	'
Non-financial assets measured at fair value	0
Non-financial liabilities measured at fair value	$0

[1]	Included in other current assets in our unaudited condensed consolidated balance sheet

Shareholders_Equity_Share_Repu

Shareholders' Equity (Share Repurchase Program and Dividends) (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013
Shareholders Equity (Textuals) [Abstract]	'	'
Cash dividend paid, per share	$0.25	$0.17
Payments of Ordinary Dividends, Ordinary Shares	$62	$42
2013 Share Repurchase Plan [Member]	'	'
Shareholders Equity (Textuals) [Abstract]	'	'
Stock Repurchased, shares	0.3	'
Repurchase of shares in cash	$12	'
Weighted average price per share	$43.50	'

Shareholders_Equity_Share_Base

Shareholders' Equity (Share Based Compensation Expense) (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013	Nov. 03, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Allocated share-based compensation expense	$24	$18	'
Cost of Products Sold [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Allocated share-based compensation expense	3	2	'
Research and Development [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Allocated share-based compensation expense	8	7	'
Selling, General and Administrative [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Allocated share-based compensation expense	$13	$9	'
Employee Stock Option [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	15	'	10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$11.57	$13.32	'

Shareholders_Equity_WeightedAv

Shareholders' Equity (Weighted-Average Assumptions) (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Outstanding Options	23	'
Weighted Average Remaining Contractual Term in years	'5 years 6 months 25 days	'
Employee Stock Option [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$11.57	$13.32
Weighted average assumptions of share-based payment awards	'	'
Risk-free interest rate	1.20%	0.70%
Dividend yield	2.00%	1.90%
Volatility	35.00%	52.00%
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	$165	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'4 years 2 months 13 days	'5 years
Market Based Options [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$19.10	'
Weighted average assumptions of share-based payment awards	'	'
Risk-free interest rate	2.40%	'
Dividend yield	1.90%	'
Volatility	46.00%	'
Employee Stock Purchase Plan [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$12.16	$11.54
Weighted average assumptions of share-based payment awards	'	'
Risk-free interest rate	0.00%	0.10%
Dividend yield	2.30%	1.80%
Volatility	37.00%	45.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'6 months	'6 months
Restricted Stock Units (RSUs) [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$46.60	$34.83
Weighted average assumptions of share-based payment awards	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	$38	'
Range One [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'4 years 3 months 7 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$8.44	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$8.01	'
Range Two [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Outstanding Options	2	'
Weighted Average Remaining Contractual Term in years	'4 years 9 months 25 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$13.39	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$13.31	'
Range Three [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Outstanding Options	2	'
Weighted Average Remaining Contractual Term in years	'6 years 4 months 23 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$21.02	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$20.87	'
Range Four [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Outstanding Options	16	'
Weighted Average Remaining Contractual Term in years	'5 years 6 months 24 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$35.44	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$33.95	'
Range Five [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'6 years 8 months 20 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$45.55	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0	'
Range Six [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'6 years 11 months 3 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$52.77	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0	'

Shareholders_Equity_Share_Base1

Shareholders' Equity (Share Based Compensation Expense) (Details Textuals) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected Life Of Options And Implied Volatility Description	'For the fiscal quarter ended FebruaryÂ 2, 2014, expected volatility for time-based options is based on our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from our own traded shares with a term of 180Â days measured at a specific date. Prior to fiscal year 2014, expected volatility was based on the combination of historical volatility of guideline publicly-traded companies and our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from traded options in guideline publicly-traded companies and our own shares with a term of 720Â days or greater measured over the last three months.	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$10	$8
Employee Stock Option [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	'3 years	'
Weighted-average fair values of options granted	$11.57	$13.32
Total compensation cost related to unvested options	165	'
Restricted Stock Units (RSUs) [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$38.37	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	'3 years	'
Total compensation cost related to unvested options	38	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value	$1	'

Shareholders_Equity_Equity_Inc

Shareholders' Equity (Equity Incentive Award Plans) (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013	Nov. 03, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of Outstanding Options	23	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value	$22	$25	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]	'	'	'
Number Outstanding, Beginning Balance	22	'	'
Weighted-Average Exercise Price Per Share, Beginning Balance	$29.81	'	'
Annual increase, Awards Available for Grant	6	'	'
Share Based Compensation Arrangement By Share Based Payment Award Shares Granted From Shares Available For Grant	1	'	'
Granted, Number Outstanding	1	'	'
Granted, Weighted-Average Exercise Price Per Share	$50.08	'	'
Exercised, Number Outstanding	0	'	'
Exercised, Weighted-Average Exercise Price Per Share	$23.46	'	'
Share Based Compensation Arrangement By Share Based Payment Award Shares Cancelled From Shares Available For Grant	0	'	'
Cancelled, Number Outstanding	0	'	'
Cancelled, Weighted-Average Exercise Price Per Share	$34.59	'	'
Weighted-Average Exercise Price Per Share, Ending Balance	$31.21	'	'
Weighted Average Remaining Contractual Term in years	'5 years 6 months 25 days	'	'
Aggregate Intrinsic Value, Ending Balance	531	'	'
Vested, Number Outstanding	7	'	'
Vested, Weighted-Average Exercise Price Per Share	$21.02	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	'4 years 11 months 10 days	'	'
Vested, Aggregate Intrinsic Value	229	'	'
Vested and expected to vest, Number Outstanding	22	'	'
Vested and expected to vest, Weighted-Average Exercise Price Per Share	$30.82	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	'5 years 6 months 10 days	'	'
Vested and expected to vest, Aggregate Intrinsic Value	$512	'	'
Restricted Stock Units (RSUs) [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	2	'	2
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$35.27	'	$34.38
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	0	'	'
Weighted-average fair value, other than options	$46.60	$34.83	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	0	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	$34.86	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	0	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$38.37	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	'2 years 9 months 18 days	'	'
Employee Stock Option [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]	'	'	'
Awards Available for Grant, Beginning Balance	'	'	10
Awards Available for Grant, Ending Balance	15	'	10
Employee Stock [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]	'	'	'
Awards Available for Grant, Ending Balance	9.3	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'	'	'
Weighted-average fair value, other than options	$12.16	$11.54	'

Shareholders_Equity_Significan

Shareholders' Equity (Significant Ranges of Outstanding and Exercisable Awards) (Details) (USD $)	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Feb. 02, 2014	Nov. 03, 2013
Ranges of outstanding and exercisable awards	'	'
Number of Outstanding Options	23	'
Weighted Average Remaining Contractual Term in years	'5 years 6 months 25 days	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$31.21	$29.81
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	7	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$21.02	'
0.00-10.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$0	'
Exercise Prices, Maximum	$10	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'4 years 3 months 7 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$8.44	'
Number of Exercisable Options	1	'
Weighted-Average Exercise Price Per Share for exercisable options	$8.01	'
10.01-20.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$10.01	'
Exercise Prices, Maximum	$20	'
Number of Outstanding Options	2	'
Weighted Average Remaining Contractual Term in years	'4 years 9 months 25 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$13.39	'
Number of Exercisable Options	2	'
Weighted-Average Exercise Price Per Share for exercisable options	$13.31	'
20.01-30.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$20.01	'
Exercise Prices, Maximum	$30	'
Number of Outstanding Options	2	'
Weighted Average Remaining Contractual Term in years	'6 years 4 months 23 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$21.02	'
Number of Exercisable Options	1	'
Weighted-Average Exercise Price Per Share for exercisable options	$20.87	'
30.01-40.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$30.01	'
Exercise Prices, Maximum	$40	'
Number of Outstanding Options	16	'
Weighted Average Remaining Contractual Term in years	'5 years 6 months 24 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$35.44	'
Number of Exercisable Options	3	'
Weighted-Average Exercise Price Per Share for exercisable options	$33.95	'
40.01-50.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$40.01	'
Exercise Prices, Maximum	$50	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'6 years 8 months 20 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$45.55	'
Number of Exercisable Options	0	'
Weighted-Average Exercise Price Per Share for exercisable options	$0	'
50.01-53.78 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$50.01	'
Exercise Prices, Maximum	$53.78	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'6 years 11 months 3 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$52.77	'
Number of Exercisable Options	0	'
Weighted-Average Exercise Price Per Share for exercisable options	$0	'

Shareholders_Equity_Employee_S

Shareholders' Equity (Employee Share Purchase Plan) (Details)	3 Months Ended
In Millions, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Stock Issued During Period, Shares, Employee Stock Purchase Plans	0	0
Employee Stock [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Shares available for issuance under the ESPP	9.3	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013	Nov. 03, 2013
Income Tax Contingency [Line Items]	'	'	'
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	$4	'	'
Provision for income taxes	5	1	'
Deferred Charge, Current	4	'	'
Deferred Charge, Non-Current	28	'	'
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	'	'	35
Tax benefit, reinstatement of research and development tax credits	'	3	'
Deferred Charge, Total	32	'	'
Minimum [Member]	'	'	'
Income Tax Contingency [Line Items]	'	'	'
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	1	'	'
Maximum [Member]	'	'	'
Income Tax Contingency [Line Items]	'	'	'
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	$13	'	'

Segment_Information_Details

Segment Information (Details)	3 Months Ended
Segment Information (Details)	Feb. 02, 2014
Segment Reporting Information [Line Items]	'
Number of Reportable Segments	1

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Feb. 02, 2014	Feb. 03, 2013		Nov. 03, 2013
Related Party Transaction [Line Items]	'	'		'
Related Party Transaction, Amounts of Transaction	$0.50	'		'
Revenue from Related Parties	0	6	[1],[2]	'
Costs and operating expenses, less than $0.5 million as of February 2, 2014	0	1	[2]	'
Receivables	0	'		0	[1]
Payables, less than $0.5 million as of November 3, 2013 and February 2, 2014, respectively	$0	'		$0

[1]	(1) Amounts include net revenue for related party transactions with Wistron Corporation through the fiscal quarter ended FebruaryÂ 3, 2013. Wistron Corporation ceased to be a related party after the fiscal quarter ended AugustÂ 4, 2013.
[2]	(2) Amounts include net revenue, cost and expenses for related party transactions with eSilicon Corporation through the fiscal quarter ended FebruaryÂ 3, 2013. eSilicon Corporation ceased to be a related party after the fiscal quarter MayÂ 5, 2013.

Recovered_Sheet2

Commitments and Contingencies (Details) (USD $)	Feb. 02, 2014
In Millions, unless otherwise specified	Feb. 02, 2014
Purchase and Other Contractual Commitments	'
Purchase Commitments, Total	$143
Purchase Commitments, 2014 (remainder)	143
Purchase Commitments, 2015	0
Purchase Commitments, 2016	0
Purchase Commitments, 2017	0
Purchase Commitments, 2018	0
Purchase Commitments, 2019	0
Purchase Commitments, Thereafter	0
Other Contractual Commitments, Total	49
Other Contractual Commitments, 2014 (remainder)	14
Other Contractual Commitments, 2015	16
Other Contractual Commitments, 2016	12
Other Contractual Commitments, 2017	5
Other Contractual Commitments, 2018	2
Other Contractual Commitments, 2019	0
Other Contractual Commitments, Thereafter	0
Fort Collins Internal Fab Facility [Member]	'
Unrecorded Unconditional Purchase Obligation [Line Items]	'
Purchase Obligation	$48

Restructuring_charges_Details

Restructuring charges (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Feb. 02, 2014	Nov. 03, 2013
Restructuring Cost and Reserve [Line Items]	'	'
Payments for Restructuring	$2	'
Restructuring and Related Cost, Expected Cost Remaining	14	0
Other Noncash Expense	1	'
Other Restructuring Costs	5	'
Research and Development Expense [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Employee termination costs	8	'
Severance Costs	9	'
Business Exit Costs	1	'
Restructuring and Related Cost, Incurred Cost	10	'
Cost of Products Sold [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Employee termination costs	4	'
Severance Costs	5	'
Business Exit Costs	0	'
Restructuring and Related Cost, Incurred Cost	5	'
Selling, General and Administrative Expenses [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Severance Costs	2	'
Business Exit Costs	0	'
Restructuring and Related Cost, Incurred Cost	2	'
One-time Termination Benefits [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Payments for Restructuring	2	'
Other Noncash Expense	0	'
Employee Severance [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Expected Cost Remaining	14	0
Facility Closing [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Payments for Restructuring	0	'
Restructuring and Related Cost, Expected Cost Remaining	0	0
Other Noncash Expense	$1	'

Accumulated_Comprehensive_Inco2

Accumulated Comprehensive Income (Loss) (Details) (USD $)	3 Months Ended
Accumulated Comprehensive Income (Loss) (Details) (USD $)	Feb. 02, 2014	Feb. 03, 2013	Nov. 03, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	($7,000,000)	'	($6,000,000)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	1,000,000	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	3,000,000	'	'
Other Nonoperating Income (Expense)	0	2,000,000	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	-3,000,000	0	'
Other Comprehensive Income (Loss), Tax	1,000,000	'	'
Other Comprehensive Income (Loss), Net of Tax	-1,000,000	2,000,000	'
prior service cost [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	-1,000,000	'	-1,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	1,000,000	'	'
Other Comprehensive Income (Loss), Tax	0	'	'
Other Comprehensive Income (Loss), Net of Tax	0	'	'
prior service cost [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	-1,000,000	'	'
Actuarial G/L [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	-6,000,000	'	-5,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	0	'	'
Other Comprehensive Income (Loss), Tax	1,000,000	'	'
Other Comprehensive Income (Loss), Net of Tax	-1,000,000	'	'
Actuarial G/L [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	-2,000,000	'	'
Selling, General and Administrative Expenses [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Plans, before tax	1,000,000	0	'
Research and Development Expense [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Plans, before tax	1,000,000	0	'
Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Plans, before tax	$1,000,000	$0	'

Subsequent_Events_Details

Subsequent Events (Details) (Dividend Declared [Member], USD $)	3 Months Ended
	Feb. 02, 2014	Mar. 05, 2014
Dividend Declared [Member]	'	'
Subsequent Event [Line Items]	'	'
Common Stock dividend declared date	5-Mar-14	'
Interim cash dividend per share	'	$0.27
Dividends Payable, Date to be Paid	31-Mar-14	'
Common Stock dividend record date	20-Mar-14	'